Cromolyn Sodium (Sandoz Inc)
Welcome to the PulseAid listing for the Cromolyn Sodium drug offered from Sandoz Inc. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Cromolyn Sodium |
SUBSTANCE NAME: | CROMOLYN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1999-06-29 |
END MARKETING DATE: | 0000-00-00 |
Cromolyn Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Cromolyn Sodium from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/mL) |
START MARKETING DATE: | 1999-06-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-237_d0c5f8f0-bcea-497c-bbad-0cba6c608ecf |
PRODUCT NDC: | 61314-237 |
APPLICATION NUMBER: | ANDA075282 |
Other CROMOLYN SODIUM Pharmaceutical Manufacturers / Labelers: